Following the successful launch of MarginProbe, this financing provides the necessary resources to expand the sales and marketing efforts for Dune's first product, the MarginProbe System for breast cancer surgery patients. The investors in this financing are both previous and new investors, including the
"We are thrilled that the MarginProbe is so well received in the U.S., and that patients and surgeons are seeing consistently strong results," said CEO Dr.
The MarginProbe System, which received Pre-Market Approval (PMA) from the
Keywords for this news article include: Cancer, Surgery, Oncology, Dune Medical Devices.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC
Most Popular Stories
- James Foley Beheading Video Is Real Thing: White House
- McDonald's Packages Coffee for National Distribution
- Faith Groups Divest From Fossil Fuels
- Apple Stock Bounces Back Big Time
- Notes From the July FOMC Meeting
- Castro-Blanco Joins Fifth Street Finance Board
- Ballmer Steps Down From Microsoft Board
- Honda's Safe Approach Pays Off in Sales
- GE Healthcare Bringing Jobs to Massachusetts
- Target Slashes Annual Profit Outlook